【AEA 2021 Alumni】
Cartosense’s vision is to make targeted surgery more precise and accessible. Cartosense has developed the world’s first mobile surgical navigation product – reducing a 200kg capital equipment product constrained to the OT, into a mobile unit that fits into a briefcase. Surgical navigation is technology that tracks the surgeon’s instruments while operating on a patient and provides real-time feedback about the current position and trajectory of an instrument with respect to the patient’s MRI/CT images. This makes it almost like a GPS system for the surgeon – only accurate to the millimetre level.
Our breakthrough product is a result of deep expertise in optics, mathematical modelling, computer vision, graphics, and precision engineering. In upcoming improvements to our platform, we are advancing the state of precision surgery through AR/VR and robotics.
Surgical navigation is currently an already established $900M market globally, of which the developed world is a $600M market and the developing world is a high growth $300M market. With increasing penetration in spine and orthopedic surgery and adoption in new applications within ENT, dental surgery, the global surgical navigation market is expected to become a $3B+ market in the next decade. Our technology aims to democratize surgical navigation by accelerating penetration in emerging markets and developing new clinical and business use cases through reverse innovation in the developed markets.